← All trials
NCT00839449
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2004
- Primary completion
- Jun 1, 2008
- Completion date
- Dec 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Yamaguchi UniversityLead sponsor
- Nakamura Memorial HospitalCollaborator
- Ootemachi HospitalCollaborator
- Yamaguchi UniversityOverall official - principal investigator
- Iwate Medical UniversityCollaborator
- Tohoku UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.